186 related articles for article (PubMed ID: 27088717)
61. [Inhibitory effect of tripeptide compound tyroservaltide on invasion and metastasis of mouse melanoma cell line B16-F10].
Che XC; Lu R; Hu JX; Zheng MN; Zhang MF; Wang S; Yu CY; Yang XL; Xing DH; Yao Z
Ai Zheng; 2006 Mar; 25(3):275-80. PubMed ID: 16536978
[TBL] [Abstract][Full Text] [Related]
62. Phenotypic profiling of engineered mouse melanomas with manipulated histamine production identifies histamine H2 receptor and rho-C as histamine-regulated melanoma progression markers.
Pós Z; Sáfrány G; Müller K; Tóth S; Falus A; Hegyesi H
Cancer Res; 2005 May; 65(10):4458-66. PubMed ID: 15899839
[TBL] [Abstract][Full Text] [Related]
63. Enhancement of gene expression by transcriptional activation using doxorubicin-loaded liposome/pDNA complexes.
Un K; Kono Y; Yoshida M; Yamashita F; Kawakami S; Hashida M
Pharmazie; 2012 May; 67(5):400-5. PubMed ID: 22764571
[TBL] [Abstract][Full Text] [Related]
64. Enhanced metastasis of B16 melanoma cells by unexpected elevated expression of the metastasis-associated TI-241 (LRF-1-, Jun-Fos-related) gene treated with antisense oligonucleotide.
Ishiguro T; Naito M; Hanaoka K; Nagawa H; Muto T; Tsuruo T
Clin Exp Metastasis; 1998 Feb; 16(2):179-83. PubMed ID: 9514099
[TBL] [Abstract][Full Text] [Related]
65. In vivo interferon regulatory factor 3 tumor suppressor activity in B16 melanoma tumors.
Duguay D; Mercier F; Stagg J; Martineau D; Bramson J; Servant M; Lin R; Galipeau J; Hiscott J
Cancer Res; 2002 Sep; 62(18):5148-52. PubMed ID: 12234977
[TBL] [Abstract][Full Text] [Related]
66. Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment.
Yu D; Li W; Zhang Y; Zhang B
Biomed Pharmacother; 2016 Oct; 83():1428-1435. PubMed ID: 27592131
[TBL] [Abstract][Full Text] [Related]
67. Effects of the CDT6/ANGX gene on tumour growth in immune competent mice.
Bouïs D; Hospers GA; Meijer C; Dam W; Peek R; Mulder NH
In Vivo; 2003; 17(2):157-61. PubMed ID: 12792978
[TBL] [Abstract][Full Text] [Related]
68. Tumor cell surface display of immunoglobulin heavy chain Fc by gene transfer as a means to mimic antibody therapy.
Riddle DS; Sanz L; Chong H; Thompson J; Vile RG
Hum Gene Ther; 2005 Jul; 16(7):830-44. PubMed ID: 16000065
[TBL] [Abstract][Full Text] [Related]
69. Effect of local tumor irradiation and interleukin-2 therapy in different murine tumors.
Lam JS; Hillman GG; Younes E; Ali E; Maughan RL; Montecillo EJ; Pontes JE; Haas GP
J Immunother Emphasis Tumor Immunol; 1995 Jul; 18(1):28-34. PubMed ID: 8535568
[No Abstract] [Full Text] [Related]
70. Gene therapy of melanoma pulmonary metastasis by intramuscular injection of plasmid DNA encoding tissue inhibitor of metalloproteinases-1.
Shi Y; Parhar RS; Zou M; Al-Mohanna FA; Paterson MC
Cancer Gene Ther; 2002 Feb; 9(2):126-32. PubMed ID: 11857029
[TBL] [Abstract][Full Text] [Related]
71. Inhibition of experimental lung metastasis by aerosol delivery of PEI-p53 complexes.
Gautam A; Densmore CL; Waldrep JC
Mol Ther; 2000 Oct; 2(4):318-23. PubMed ID: 11020346
[TBL] [Abstract][Full Text] [Related]
72. Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector.
Cemazar M; Sersa G; Wilson J; Tozer GM; Hart SL; Grosel A; Dachs GU
Cancer Gene Ther; 2002 Apr; 9(4):399-406. PubMed ID: 11960291
[TBL] [Abstract][Full Text] [Related]
73. [Inhibitory effect of ginsenoside-Rg3 on lung metastasis of mouse melanoma transfected with ribonuclease inhibitor].
Liu JW; Chen JX; Yu LH; Tian YX; Cui XY; Yan Q; Fu L
Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):722-5. PubMed ID: 15733388
[TBL] [Abstract][Full Text] [Related]
74. Viral vector mimicking and nucleus targeted nanoparticles based on dexamethasone polyethylenimine nanoliposomes: Preparation and evaluation of transfection efficiency.
Malaekeh-Nikouei B; Gholami L; Asghari F; Askarian S; Barzegar S; Rezaee M; Kazemi Oskuee R
Colloids Surf B Biointerfaces; 2018 May; 165():252-261. PubMed ID: 29494955
[TBL] [Abstract][Full Text] [Related]
75. Replicase-based plasmid DNA shows anti-tumor activity.
Rodriguez BL; Yu Z; Chung WG; Weiss R; Cui Z
BMC Cancer; 2011 Mar; 11():110. PubMed ID: 21443770
[TBL] [Abstract][Full Text] [Related]
76. Gelsolin functions as a metastasis suppressor in B16-BL6 mouse melanoma cells and requirement of the carboxyl-terminus for its effect.
Fujita H; Okada F; Hamada J; Hosokawa M; Moriuchi T; Koya RC; Kuzumaki N
Int J Cancer; 2001 Sep; 93(6):773-80. PubMed ID: 11519036
[TBL] [Abstract][Full Text] [Related]
77. Intratumoral injection of PKR shRNA expressing plasmid inhibits B16-F10 melanoma growth.
André ND; Silva VA; Watanabe MA; De Lucca FL
Oncol Rep; 2014 Nov; 32(5):2267-73. PubMed ID: 25175769
[TBL] [Abstract][Full Text] [Related]
78. Lipoplex-based targeted gene therapy for the suppression of tumours with VEGFR expression by producing anti-angiogenic molecules.
Ho SY; Chen PR; Chen CH; Tsai NM; Lin YH; Lin CS; Chuang CH; Huang XF; Chan YL; Liu YK; Chung CH; Weng SL; Liao KW
J Nanobiotechnology; 2020 Apr; 18(1):58. PubMed ID: 32272948
[TBL] [Abstract][Full Text] [Related]
79. RNASET2 as a tumor antagonizing gene in a melanoma cancer model.
Monti L; Rodolfo M; Lo Russo G; Noonan D; Acquati F; Taramelli R
Oncol Res; 2008; 17(2):69-74. PubMed ID: 18543608
[TBL] [Abstract][Full Text] [Related]
80. Effect of pEgr-TNFalpha gene radiotherapy on mice melanoma.
Wu C; Li X; Tian M
Melanoma Res; 2005 Jun; 15(3):185-90. PubMed ID: 15917700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
